{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T08:16:57Z","timestamp":1769847417259,"version":"3.49.0"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T00:00:00Z","timestamp":1591920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009148","name":"Queen Mary University of London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009148","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2020.00464","type":"journal-article","created":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T04:55:00Z","timestamp":1591937700000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Can We Improve the Monitoring of People With Multiple Sclerosis Using Simple Tools, Data Sharing, and Patient Engagement?"],"prefix":"10.3389","volume":"11","author":[{"given":"Kimberley","family":"Allen-Philbey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rod","family":"Middleton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie","family":"Tuite-Dalton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Stennett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christo","family":"Albor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Schmierer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,6,12]]},"reference":[{"key":"B1","unstructured":"Public Health EnglandMultiple Sclerosis: Prevalence, Incidence And Smoking Status\u2013Data Briefing2020"},{"key":"B2","unstructured":"MS SocietyMS Incidence and Prevalence Report2020"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e1029","DOI":"10.1212\/WNL.0000000000007035","article-title":"The prevalence of MS in the United States: A population-based estimate using health claims data","volume":"92","author":"Wallin","year":"2019","journal-title":"Neurology."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1093\/brain\/awq076","article-title":"Evidence for a two-stage disability progression in multiple sclerosis","volume":"133","author":"Leray","year":"2010","journal-title":"Brain."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1093\/brain\/awq118","article-title":"The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability","volume":"133","author":"Scalfari","year":"2010","journal-title":"Brain."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1177\/1352458518809326","article-title":"International consensus on quality standards for brain health-focused care in multiple sclerosis","volume":"25","author":"Hobart","year":"2019","journal-title":"Mult Scler."},{"key":"B7","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa1601277","article-title":"Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis","volume":"376","author":"Hauser","year":"2017","journal-title":"N Engl J Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1177\/1352458518808189","article-title":"Ocrelizumab reduces progression of upper extremity impairment in patients with primary progressive multiple sclerosis: Findings from the phase III randomized ORATORIO trial","volume":"24","author":"Fox","year":"2018","journal-title":"Multiple Sclerosis J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S1474-4422(18)30069-3","article-title":"Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension","volume":"17","author":"Kapoor","year":"2018","journal-title":"Lancet Neurol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/S0140-6736(18)30475-6","article-title":"Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study","volume":"391","author":"Kappos","year":"2018","journal-title":"Lancet."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1177\/1352458515616205","article-title":"A comparative analysis of patient-reported expanded disability status scale tools","volume":"22","author":"Collins","year":"2016","journal-title":"Multiple Sclerosis J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology."},{"key":"B13","unstructured":"NHSEngland\n          Treatment Algorithm for Multiple Sclerosis Disease-Modifying Therapies2018"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1177\/1352458517717811","article-title":"Disease modification in advanced MS: Focus on upper limb function","volume":"23","author":"Dubuisson","year":"2017","journal-title":"Mult Scler."},{"key":"B15","unstructured":"RobertsM\n            BowenA\n          LetchworthMS TrustImproving Services for People With Advanced MS2016"},{"key":"B16","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1002\/acn3.410","article-title":"Cladribine to treat disease exacerbation after fingolimod discontinuation in progressive multiple sclerosis","volume":"4","author":"Alvarez-Gonzalez","year":"2017","journal-title":"Ann Clin Trans Neurol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.msard.2018.11.001","article-title":"Treating the ineligible: Disease modification in people with multiple sclerosis beyond NHS England commissioning policies","volume":"27","author":"Mao","year":"2019","journal-title":"Mult Scler Relat Disord."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1007\/s00415-013-7004-1","article-title":"Validating a novel web-based method to capture disease progression outcomes in multiple sclerosis","volume":"260","author":"Leddy","year":"2013","journal-title":"J Neurol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1212\/WNL.41.5.685","article-title":"Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction","volume":"41","author":"Rao","year":"1991","journal-title":"Neurology."},{"key":"B20","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.msard.2018.09.018","article-title":"How does cognition relate to employment in multiple sclerosis? A systematic review","volume":"26","author":"Clemens","year":"2018","journal-title":"Mult Scler Relat Disord."},{"key":"B21","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1191\/135245899678846168","article-title":"The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment","volume":"5","author":"Fischer","year":"1999","journal-title":"Mult Scler."},{"key":"B22","unstructured":"Clin Trials.2019"},{"key":"B23","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1177\/1352458509354552","article-title":"Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test","volume":"16","author":"Drake","year":"2010","journal-title":"Mult Scler."},{"key":"B24","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1177\/1352458511431076","article-title":"Recommendations for a brief international cognitive assessment for multiple sclerosis (BICAMS)","volume":"18","author":"Langdon","year":"2012","journal-title":"Multiple Sclerosis J."},{"key":"B25","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1177\/1352458518803769","article-title":"Inclusion criteria used in trials of people with progressive multiple sclerosis","volume":"26","author":"Dubuisson","year":"2020","journal-title":"Mult Scler."},{"key":"B26","doi-asserted-by":"publisher","first-page":"A24","DOI":"10.1016\/j.jval.2015.03.149","article-title":"Measuring upper limb function in multiple sclerosis: Enhancing the ABILHAND's performance","volume":"18","author":"Cano","year":"2015","journal-title":"Value Health."},{"key":"B27","unstructured":"Patient registries [online]Eur Med Agency"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1177\/1352458518799629","article-title":"e-Health and multiple sclerosis: An update","volume":"24","author":"Lavorgna","year":"2018","journal-title":"Mult Scler."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.3109\/09638280903567885","article-title":"Validation of the patient activation measure in a multiple sclerosis clinic sample and implications for care","volume":"32","author":"Stepleman","year":"2010","journal-title":"Disabil Rehabil."},{"key":"B30","volume-title":"Treatment Decision Making and Relapsing Remitting Multiple Sclerosis. The CRIMSON Project Decision Aid Booklet.","author":"Manzano","year":"2019"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1007\/s12325-019-01071-9","article-title":"Joint healthcare professional and patient development of communication tools to improve the standard of MS care","volume":"36","author":"Oreja-Guevara","year":"2019","journal-title":"Adv Ther."},{"key":"B32","doi-asserted-by":"publisher","first-page":"101525","DOI":"10.1016\/j.msard.2019.101525","article-title":"Technology-enabled comprehensive characterization of multiple sclerosis in clinical practice","volume":"38","author":"Baldassari","year":"2019","journal-title":"Mult Scler Relat Disord."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e14863","DOI":"10.2196\/14863","article-title":"Adherence and satisfaction of smartphone- and smartwatch-based remote active testing and passive monitoring in people with multiple sclerosis: nonrandomized interventional feasibility study","volume":"21","author":"Midaglia","year":"2019","journal-title":"J Med Internet Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.msard.2017.08.002","article-title":"Validation of an environmentally-friendly and affordable cardboard 9-hole peg test","volume":"17","author":"Dubuisson","year":"2017","journal-title":"Mult Scler Relat Disord."},{"key":"B35","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1177\/1352458518798591","article-title":"Systematic multidimensional clinical point-of-care monitoring of people with multiple sclerosis using 3TEST","volume":"24","author":"Allen-Philbey","year":"2018","journal-title":"Multiple Sclerosis J."},{"key":"B36","unstructured":"MiddletonR\n            PearsonO\n            IngramG\n            WatsonL\n            CraigE\n            RobertsC\n          ECTRIMS Online LibraryMSiDMT: Development of a Consistent Electronic Cognitive Scoring Method for the UKMS Register2019"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/7627643","article-title":"The role of wearable devices in multiple sclerosis","volume":"2018","author":"Sparaco","year":"2018","journal-title":"Multiple Sclerosis Int."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.3389\/fneur.2019.01206","article-title":"Efficiency and patient-reported outcome measures from clinic to home: the human empowerment aging and disability program for digital-health rehabilitation","volume":"10","author":"Isernia","year":"2019","journal-title":"Front Neurol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2055217318813736","DOI":"10.1177\/2055217318813736","article-title":"Successful utilization of the EMR in a multiple sclerosis clinic to support quality improvement and research initiatives at the point of care","volume":"4","author":"Claire Simon","year":"2018","journal-title":"Mult Scler J Exp Transl Clin."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1136\/jnnp-2013-306573.170","article-title":"Using routine point-of-care data for research: the east London multiple sclerosis cohort","volume":"84","author":"Albor","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.msard.2018.05.015","article-title":"Validating the portal population of the United Kingdom Multiple Sclerosis Register","volume":"24","author":"Middleton","year":"2018","journal-title":"Mult Scler Relat Disord."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e55422","DOI":"10.1371\/journal.pone.0055422","article-title":"The physical and psychological impact of multiple sclerosis using the MSIS-29 via the web portal of the UK MS Register","volume":"8","author":"Jones","year":"2013","journal-title":"PLoS ONE."},{"key":"B43","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/1471-2377-13-119","article-title":"The multiple sclerosis relapse experience: patient-reported outcomes from the North American Research Committee on Multiple Sclerosis (NARCOMS) Registry","volume":"13","author":"Nickerson","year":"2013","journal-title":"BMC Neurol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"g7818","DOI":"10.1136\/bmj.g7818","article-title":"Patient reported outcome measures in practice","volume":"350","author":"Nelson","year":"2015","journal-title":"BMJ."},{"key":"B45","doi-asserted-by":"publisher","first-page":"e65640","DOI":"10.1371\/journal.pone.0065640","article-title":"How people with multiple sclerosis rate their quality of life: an EQ-5D survey via the UK MS register","volume":"8","author":"Jones","year":"2013","journal-title":"PLoS ONE."},{"key":"B46","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1136\/jnnp.73.6.701","article-title":"Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples","volume":"73","author":"Riazi","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B47","doi-asserted-by":"publisher","first-page":"105","DOI":"10.7224\/1537-2073.2013-013","article-title":"Validation of mood measures for people with multiple sclerosis","volume":"16","author":"Watson","year":"2014","journal-title":"Int J MS Care."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","article-title":"The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus","volume":"46","author":"Krupp","year":"1989","journal-title":"Arch Neurol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1212\/WNL.60.1.31","article-title":"Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12)","volume":"60","author":"Hobart","year":"2003","journal-title":"Neurology."},{"key":"B50","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1471-2377-13-37","article-title":"Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis","volume":"13","author":"Learmonth","year":"2013","journal-title":"BMC Neurol."},{"key":"B51","unstructured":"National Multiple Sclerosis Society: Clinical Outcome Measures"},{"key":"B52","unstructured":"ClinicSpeak"},{"key":"B53","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform."},{"key":"B54","doi-asserted-by":"publisher","first-page":"51318","DOI":"10.3791\/51318","article-title":"The multiple sclerosis performance test (MSPT): an iPad-based disability assessment tool","volume":"2014","author":"Rudick","year":"2014","journal-title":"J Vis Exp"},{"key":"B55","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1177\/1352458506070775","article-title":"MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosis","volume":"12","author":"Butzkueven","year":"2006","journal-title":"Mult Scler."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s10072-020-04391-9","article-title":"Digital triage for people with multiple sclerosis in the age of COVID-19 pandemic","volume":"41","author":"Bonavita","year":"2020","journal-title":"Neurol Sci"},{"key":"B57","unstructured":"Floodlight Open2020"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2020.00464\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T04:55:06Z","timestamp":1591937706000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2020.00464\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,12]]},"references-count":57,"alternative-id":["10.3389\/fneur.2020.00464"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2020.00464","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,12]]},"article-number":"464"}}